Telling the Story of Stepfamily Beginnings: The Relationship between Young-adult Stepchildren’s Stepfamily Origin Stories and their Satisfaction with the Stepfamily

The current study adopts a narrative perspective in examining the content of 80 stepchildren’s stepfamily origin stories. Results reveal five types of stepfamily origin stories: Sudden, Dark-sided, Ambivalent, Idealized, and Incremental. Results support the hypothesis that story type would predict differences in family satisfaction; stepchildren who described their stepfamily origins as Idealized were more satisfied than those whose origins were Dark-sided or Sudden. Overall, participants framed their stepfamily identity more positively when their stepfamily beginnings were characterized by closeness, friendship, and even expected ups and downs, rather than when they were left out of the process of negotiating or forming the stepfamily and when the beginnings were tainted by issues they considered to be dark. Stepparents or practitioners may benefit from these findings by examining the means by which stepparents may involve stepchildren in the process of stepfamily courtship, facilitate closeness, and set up realistic expectations for negotiating stepfamily life

Factors affecting the indoor concentrations of carbonaceous aerosols of outdoor origin

A field study was conducted in an unoccupied single story residence in Clovis, California to provide data to address issues important to assess the indoor exposure to particles of outdoor origin. Measurements of black and organic carbonaceous aerosols were performed using a variety of methods, resulting in both near real-time measurements as well as integrated filter based measurements. Comparisons of the different measurement methods show that it is crucial to account for gas phase adsorption artifacts when measuring organic carbon (OC). Measured concentrations affected by the emissions of organic compounds sorbed to indoor surfaces imply a higher degree of infiltration of outdoor organic carbon aerosols into the indoor environment for our unoccupied house. Analysis of the indoor and outdoor data for black carbon (BC) aerosols show that, on average, the indoor concentration of black carbon aerosols behaves in a similar manner to sulfate aerosols. In contrast, organic carbon aerosols are subject to chemical transformations indoors that, for our unoccupied home, resulted in lower indoor OC concentrations than would be expected by physical loss mechanisms alone. These results show that gas to particle partitioning of organic compounds, as well as gas to surface interactions within the residence, are an important process governing the indoor concentration to OC aerosols of outdoor origin

Air quality and error quantity: pollution and performance in a high-skilled, quality-focused occupation

We provide the first evidence that short-term exposure to air pollution affects the work performance of a group of highly-skilled, quality-focused employees. We repeatedly observe the decision-making of individual professional baseball umpires, quasi-randomly assigned to varying air quality across time and space. Unique characteristics of this setting combined with high-frequency data disentangle effects of multiple pollutants and identify previously under-explored acute effects. We find a 1 ppm increase in 3-hour CO causes an 11.5% increase in the propensity of umpires to make incorrect calls and a 10 mg/m3 increase in 12-hour PM2.5 causes a 2.6% increase. We control carefully for a variety of potential confounders and results are supported by robustness and falsification checks

Identity Work and Organizational Identification

In this paper, I analyse five approaches to identity work - discursive, dramaturgical, symbolic, socio-cognitive, and psychodynamic - and show how these are helpful in exploring the ways people draw on their membership of organizations in their constructions of self, processes generally referred to as organizational identification. Collectively, these approaches constitute a distinctive perspective on identities and identifications which suggests that they are ‘worked on’ by embedded social actors who are both constrained and enabled by context. In so doing, I draw attention to issues of agency and process, the always dynamic and complex, often fractured, and sometimes contradictory nature of identities and identifications, and raise a series of issues and questions for further research

Efficacy and safety of baricitinib or ravulizumab in adult patients with severe COVID-19 (TACTIC-R): a randomised, parallel-arm, open-label, phase 4 trial

Background From early in the COVID-19 pandemic, evidence suggested a role for cytokine dysregulation and complement activation in severe disease. In the TACTIC-R trial, we evaluated the efficacy and safety of baricitinib, an inhibitor of Janus kinase 1 (JAK1) and JAK2, and ravulizumab, a monoclonal inhibitor of complement C5 activation, as an adjunct to standard of care for the treatment of adult patients hospitalised with COVID-19. Methods TACTIC-R was a phase 4, randomised, parallel-arm, open-label platform trial that was undertaken in the UK with urgent public health designation to assess the potential of repurposing immunosuppressants for the treatment of severe COVID-19, stratified by a risk score. Adult participants (aged ≥18 years) were enrolled from 22 hospitals across the UK. Patients with a risk score indicating a 40% risk of admission to an intensive care unit or death were randomly assigned 1:1:1 to standard of care alone, standard of care with baricitinib, or standard of care with ravulizumab. The composite primary outcome was the time from randomisation to incidence (up to and including day 14) of the first event of death, invasive mechanical ventilation, extracorporeal membrane oxygenation, cardiovascular organ support, or renal failure. The primary interim analysis was triggered when 125 patient datasets were available up to day 14 in each study group and we included in the analysis all participants who were randomly assigned. The trial was registered on ClinicalTrials.gov (NCT04390464). Findings Between May 8, 2020, and May 7, 2021, 417 participants were recruited and randomly assigned to standard of care alone (145 patients), baricitinib (137 patients), or ravulizumab (135 patients). Only 54 (39%) of 137 patients in the baricitinib group received the maximum 14-day course, whereas 132 (98%) of 135 patients in the ravulizumab group received the intended dose. The trial was stopped after the primary interim analysis on grounds of futility. The estimated hazard ratio (HR) for reaching the composite primary endpoint was 1·11 (95% CI 0·62–1·99) for patients on baricitinib compared with standard of care alone, and 1·53 (0·88–2·67) for ravulizumab compared with standard of care alone. 45 serious adverse events (21 deaths) were reported in the standard-of-care group, 57 (24 deaths) in the baricitinib group, and 60 (18 deaths) in the ravulizumab group. Interpretation Neither baricitinib nor ravulizumab, as administered in this study, was effective in reducing disease severity in patients selected for severe COVID-19. Safety was similar between treatments and standard of care. The short period of dosing with baricitinib might explain the discrepancy between our findings and those of other trials. The therapeutic potential of targeting complement C5 activation product C5a, rather than the cleavage of C5, warrants further evaluation